Translation-X Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 3

Translation-X General Information

Description

Developer of novel therapeutics intended for Autism Spectrum disorders. The company follows a precision medicine approach to address the core symptoms of autism-spectrum disorders such as social interaction difficulties, enabling its clients to tackle the challenges of autism therapy.

Contact Information

Website
www.trx-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Corporate Office
  • Spitalstrasse 41
  • 4056 Basel
  • Switzerland
+41 061
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • Spitalstrasse 41
  • 4056 Basel
  • Switzerland
+41 061

Translation-X Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Translation-X Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Accelerator/Incubator 01-Jan-2025 Completed Product Development
3. Early Stage VC 28-Aug-2024 Completed Product Development
2. Accelerator/Incubator 07-Nov-2023 $11.1K $11.1K Completed Product Development
1. Accelerator/Incubator 01-Oct-2022 Completed Product Development
To view Translation-X’s complete valuation and funding history, request access »

Translation-X Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Venture (Switzerland) Accelerator/Incubator
Venture Kick Accelerator/Incubator
Innovation Office (Accelerator/Incubator) Accelerator/Incubator
To view Translation-X’s complete investors history, request access »

Ready to get started?

Request a free trial

Translation-X FAQs

  • When was Translation-X founded?

    Translation-X was founded in 2022.

  • Where is Translation-X headquartered?

    Translation-X is headquartered in Basel, Switzerland.

  • What industry is Translation-X in?

    Translation-X’s primary industry is Drug Discovery.

  • Is Translation-X a private or public company?

    Translation-X is a Private company.

  • What is Translation-X’s current revenue?

    The current revenue for Translation-X is .

  • How much funding has Translation-X raised over time?

    Translation-X has raised $174K.

  • Who are Translation-X’s investors?

    Venture (Switzerland), Venture Kick, and Innovation Office (Accelerator/Incubator) have invested in Translation-X.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process